Arvinas Inc (NASDAQ:ARVN) Director Briggs Morrison acquired 2,500 shares of Arvinas stock in a transaction dated Tuesday, March 24th. The shares were bought at an average cost of $40.82 per share, with a total value of $102,050.00. Following the completion of the purchase, the director now owns 29,520 shares in the company, valued at $1,205,006.40. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Arvinas stock traded up $3.18 during midday trading on Thursday, hitting $44.00. The company’s stock had a trading volume of 4,524 shares, compared to its average volume of 401,671. The firm has a market capitalization of $1.48 billion, a P/E ratio of -20.85 and a beta of 2.44. The stock has a 50-day simple moving average of $46.71 and a 200-day simple moving average of $36.47. The company has a quick ratio of 8.86, a current ratio of 8.86 and a debt-to-equity ratio of 0.02. Arvinas Inc has a 1-year low of $14.06 and a 1-year high of $54.95.
Arvinas (NASDAQ:ARVN) last issued its earnings results on Monday, March 16th. The company reported ($0.56) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.54) by ($0.02). The business had revenue of $4.89 million during the quarter, compared to analyst estimates of $4.77 million. Arvinas had a negative return on equity of 30.16% and a negative net margin of 163.56%. As a group, sell-side analysts predict that Arvinas Inc will post -2.47 earnings per share for the current year.
Several institutional investors have recently modified their holdings of the company. Bank of Montreal Can boosted its stake in shares of Arvinas by 66.3% during the 4th quarter. Bank of Montreal Can now owns 2,677 shares of the company’s stock worth $110,000 after buying an additional 1,067 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in Arvinas in the fourth quarter worth about $48,000. California State Teachers Retirement System raised its position in Arvinas by 5.6% in the third quarter. California State Teachers Retirement System now owns 28,596 shares of the company’s stock worth $616,000 after acquiring an additional 1,508 shares during the period. Quantbot Technologies LP bought a new stake in Arvinas in the fourth quarter worth about $68,000. Finally, American International Group Inc. raised its position in Arvinas by 14.6% in the fourth quarter. American International Group Inc. now owns 13,284 shares of the company’s stock worth $546,000 after acquiring an additional 1,696 shares during the period. 77.22% of the stock is owned by institutional investors and hedge funds.
Arvinas Company Profile
Arvinas, Inc, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER positive/HER2 negative breast cancer.
See Also: Dividend Aristocrat Index
Receive News & Ratings for Arvinas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arvinas and related companies with MarketBeat.com's FREE daily email newsletter.